Latest

Latest AusBiotech News | Page 4

  • Latest AusBiotech news stories and updates. What is happening today? All recent AusBiotech news and developments. Live coverage and timeline of AusBiotech. All you need to know about AusBiotech.
Novel therapeutics development highlighted in Australasian Biotechnology journal
PolyNovo updates investors with significant revenue growth
US FDA grants conditional approval to the brand name of Dimerix’s DMX-200
HealthTech InnovationAus award finalists announced
BioCurate and Takeda renew alliance to accelerate discoveries
AusBiotech announces CEO departure
Moderna marks half-way point in construction of mRNA manufacturing facility
Optiscan Imaging correlates with histology in breast cancer study
Australian-developed drug receives US FDA approval
Adapt Ideations announces the appointment of chief operating officer
Early diagnosis a step closer for those at risk of oesophageal cancer
BCAL Diagnostics says it has locked down crucial breast cancer signature
Feedback sought on Employee Share Schemes policy
Imugene secures new patent in Japan for PD1-Vaxx clinical drug candidate
Actinogen Medical closes $10 million rights issue offer
FivepHusion says first patient treated in paediatric brain cancer trial
Save $350 with AusBiotech 2023 early-bird rates
Emyria announces capital raise to progress mental healthcare programs
Non-animal models could deliver $1.5B growth
Pharmaxis announces the publication of positive preclinical data for PXS-5505
Recognition for Vetter in annual Frost & Sullivan awards
ENA respiratory expands leadership team and extends US Department of Defense funding
Evaluation of MRFF’s Clinical Trials Activity initiative released
Botanix Pharmaceuticals elevates chief operating officer to CEO position
First participant treated at the highest dose level in Clarity’s theranostic prostate cancer trial
Feedback sought on FMT exemption and draft guidance
Opthea announces placement and fully underwritten entitlement offer to raise $80m
Vaxxas awarded Wellcome grant for needle-free typhoid vaccine patch study
Telix says result reflects its transition to a sustainable commercial-stage company
Nominations open for AusBiotech Board 22 August
Biotron completes clinical phase of BIT225 COVID-19 clinical trial
Imugene licenses allogeneic CAR-T with a potential registration study in 2024
CUREator+ delivers funding boost to commercially focused BioMedTech startups
AusBiotech 2023 programme launched
Chimeric reports positive in-vitro data for CHM 0301 next-generation cell platform
CSL reports strong profit growth with record plasma collections
A major day for Moderna as the company builds its Australian presence
AusBiotech 2023 Millis Orator announced
Notification of AGM 2023 and forthcoming elections
Clarity’s theranostic prostate cancer trial advances to highest dose level
Merck partners to pilot first DeadlyLabs kit
Australian vaccine breakthrough offers hope against EBV-associated cancers and MS
AusBiotech launches world-first ESG Guide for biotech SMEs
AusBiotech weighs in on Industry Growth Program consultation
Dimerix announces successful completion of second DSMB review of ACTION3 trial
Peter Mac selects BindiMaps to launch Victoria’s first hospital ‘Google Maps for indoors’
Immutep receives positive scientific advice from the European Medicines Agency
New AusBiotech report shows increasing US investment in Australian biotechs

© 2024 - The National Tribune Australia